• 2024-08-20 01:44抑制剂Afimetoran|Afimetoran|2171019-55-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
• 2024-08-20 01:44抑制剂Afimetoran|Afimetoran|2171019-55-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
• 2024-08-20 01:44抑制剂AER-271|AER-271|634913-39-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
• 2024-08-20 01:44抑制剂AF40431|AF40431|181125-92-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
• 2024-08-20 01:44抑制剂AF40431|AF40431|181125-92-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
• 2024-08-20 01:44抑制剂AF40431|AF40431|181125-92-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
• 2024-08-20 01:44抑制剂AEG3482|AEG3482|63735-71-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
• 2024-08-20 01:44抑制剂AER-271|AER-271|634913-39-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
• 2024-08-20 01:44抑制剂AER-271|AER-271|634913-39-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
• 2024-08-20 01:44抑制剂AdipoRon hydrochloride|AdipoRon hydrochloride|1781835-20-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
• 2024-08-20 01:44抑制剂AdipoRon hydrochloride|AdipoRon hydrochloride|1781835-20-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
• 2024-08-20 01:44抑制剂AEG3482|AEG3482|63735-71-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
• 2024-08-20 01:44抑制剂AEG3482|AEG3482|63735-71-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
• 2024-08-20 01:44抑制剂Adezmapimod|Adezmapimod|152121-47-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
• 2024-08-20 01:44抑制剂Adezmapimod|Adezmapimod|152121-47-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
• 2024-08-20 01:44抑制剂Adezmapimod|Adezmapimod|152121-47-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
• 2024-08-20 01:44抑制剂AdipoRon hydrochloride|AdipoRon hydrochloride|1781835-20-8|Adamas life|≥98%（以实测数值为准）|BR|100mg
• 2024-08-20 01:44抑制剂Adagrasib|Adagrasib|2326521-71-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
• 2024-08-20 01:44抑制剂Adavosertib|Adavosertib|955365-80-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
• 2024-08-20 01:44抑制剂Adavosertib|Adavosertib|955365-80-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
第185页/共69980页    首页   上一页   下一页   尾页